相关实验视频

Updated: May 29, 2025

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

在动脉样硬化中,TREM2作为治疗点

Siting Xu¹, Bo Yang¹, Wenhua Yu¹

¹Department of Cardiology, Affiliated Hospital of Jiangsu University, Zhenjiang, China.

Cell biology international

|February 1, 2025

概括

在骨髓细胞-2 (TREM2) 上表达的触发受体对于泡性巨细胞的存活和动脉样硬化进展至关重要. 向TREM2为治疗动脉样硬化提供了一个潜在的治疗策略.

科学领域:

心血管研究研究心血管研究
免疫学免疫学免疫学
分子生物学分子生物学

背景情况:

动脉样硬化涉及胆固醇载荷的动脉壁中的泡性巨细胞.
单细胞RNA测序确定了动脉样硬化斑块中的TREM2高的巨细胞.
在泡性巨细胞的生存和疾病进展中,TREM2起着关键作用.

研究的目的:

审查TREM2在动脉样硬化中的作用.
探索TREM2作为一个治疗目标.
评估基于TREM2的干预措施的临床可行性.

主要方法:

关于TREM2的基础研究的文献综述2.
对单细胞RNA测序数据的分析.
评估TREM2的治疗潜力.

主要成果:

TREM2对于泡性巨细胞扩张至关重要.
TREM2显著影响动脉样硬化进展.
TREM2 是一个有前途的治疗点.

结论:

在动脉样硬化中TREM2的作用已被证实.
准TREM2是一个可行的治疗途径.
对动脉样硬化的TREM2疗法的临床应用是可行的.

关键词:

在TREM2中,我们可以使用TREM2.动脉样硬化动脉样硬化巨细胞是一个巨细胞.

更多相关视频

Quantification of Atherosclerosis in Mice

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

相关概念视频

Enzyme-linked Receptors

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...